Top 5 Takeaways New and Updated Vaccine Recommendations: The 2024 schedule includes changes for respiratory syncytial virus (RSV), influenza, COVID-19, inactivated poliovirus vaccine (IPV), Mpox vaccine, and meningococcal vaccines. Removal

Top 5 Takeaways Bivalent mRNA COVID-19 Vaccine Effectiveness: The bivalent mRNA COVID-19 vaccine was found to be 47% effective in preventing thromboembolic events in immunocompetent persons aged ≥65 years and

Top 5 Takeaways Among 57 patients hospitalized for severe monkeypox during the study period, most were Black men with AIDS, highlighting the severe impact of monkeypox in immunocompromised individuals. Twelve

Top 5 Takeaways Prevalence and Demographics: Monkeypox virus (MPXV) infections in children and adolescents aged <18 years constituted only 0.3% of all U.S. cases during the study period, with no

Top 5 Takeaways: Safety Profile Similar to Monovalent Boosters: Early safety findings for bivalent COVID-19 mRNA booster doses in persons aged ≥12 years are consistent with those reported for monovalent

Top 5 Takeaways 1. 26,384 monkeypox cases were reported in the U.S. from May 17 to October 6, 2022, with a peak in mid-to-late August. 2. Disproportionate impact on Black

Top 5 Takeaways Outbreak of Sudan ebolavirus in Uganda: From September 18 to October 31, 2022, Uganda experienced its fifth outbreak of Ebola Virus Disease (EVD) caused by Sudan ebolavirus,

Top 5 Takeaways Bivalent Booster Recommendation: In fall 2022, the CDC recommended a bivalent mRNA COVID-19 vaccine booster dose for individuals aged 5 years and older, to be administered at